Company profile: PowderMed
1.1 - Company Overview
Company description
- Provider of Particle Mediated Epidermal Delivery (PMED) technology and vaccines for chronic infectious diseases and cancer, using DNA-coated gold particles delivered by a needle-free injection device to stimulate specific T cell immune responses.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PowderMed
DVS Sciences
HQ: United States
Website
- Description: Provider of novel bioanalytical solutions for biomarker discovery, biological research and possible clinical applications, including a patented multi-parameter high-throughput mass cytometer for quantitative individual cell analysis (CyTOF) and a suite of MAXPAR reagents; manufactures and distributes globally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DVS Sciences company profile →
Dow Pharmaceutical Sciences
HQ: United States
Website
- Description: Provider of topical drug product development services for pharmaceutical and biotechnology clients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dow Pharmaceutical Sciences company profile →
Synthego
HQ: United States
Website
- Description: Provider of genome engineering platforms enabling access to CRISPR to accelerate life science R&D, leveraging machine learning, automation, and gene editing. Offers synthetic and synthesized sgRNA/gRNA for research and therapeutic development, GMP-grade and IND-enabling sgRNA for clinical trials and pre-IND studies, and the engineered hfCas12Max nuclease for higher on-target editing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synthego company profile →
Algenex
HQ: Spain
Website
- Description: Provider of vector-based technologies to manufacture recombinant proteins via a baculovirus expression vector system, with applications in vaccines, diagnostic reagents, crystallography, HTS and therapeutic molecules. Offers CrisBio, animal vaccine development/production, and biocomponents for diagnostic and therapeutic markets in human and animal health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Algenex company profile →
Iota Sciences
HQ: United Kingdom
Website
- Description: Provider of cell biology discovery technologies, including a Cloning Platform that gently handles single cells and uses less culture medium to produce verified clonal cultures, a scPicking Platform utilizing low-volume cell chambers to isolate single cells for transfer to downstream formats, and hiPSC gene-editing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iota Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PowderMed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PowderMed
2.2 - Growth funds investing in similar companies to PowderMed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PowderMed
4.2 - Public trading comparable groups for PowderMed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →